R Squared’s Revolution Medicines RVMD Stock Holding History

R Squared’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-170	Closed	-$7.44K	–	1252
2024 Q4	$7.44K	Buy	+170	New	+$8.58K	0.01%	1229

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

R Squared's RVMD Position: Q1 2025 in Review

R Squared sold out of Revolution Medicines (RVMD) in Q1 2025, closing a stake of 170 shares — an estimated $7.44K sold.

R Squared first reported a position in RVMD in Q4 2024 and held it in 1 quarter. The position peaked at $7.44K in Q4 2024. 284 funds tracked by Wall St. Rank hold RVMD as of Q1 2025.

R Squared reported no remaining Revolution Medicines position as of Q1 2025 after selling out during the quarter.
R Squared sold 170 Revolution Medicines shares in Q1 2025, an estimated $7.44K.
R Squared first reported a position in Revolution Medicines in Q4 2024 and held it in 1 quarter.
R Squared's Revolution Medicines position peaked at $7.44K in Q4 2024.
284 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.